Antitumor activity of polyinosinic-polycytidylic acid in combination with some biologically active compounds.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000242:Cyclic AMP / Q000494:pharmacology; D003911:Dextrans / Q000494:pharmacology; D004336:Drug Antagonism; D004347:Drug Interactions; D004357:Drug Synergism; D005260:Female; D005622:Friend murine leukemia virus; D008297:Male; D051379:Mice; D011033:Podophyllin / Q000494:pharmacology; D011070:Poly I-C / Q000494:pharmacology*; D051381:Rats; D001357:Sarcoma, Avian / Q000188:drug therapy
D000970:Antineoplastic Agents; D003911:Dextrans; D011033:Podophyllin; D000242:Cyclic AMP; D011070:Poly I-C